Financial statements Stem Cell Therapies

Balance sheet of Stem Cell Therapies

Company age:
Age:
9 y. 9 m. 13 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of STEM CELL THERAPIES

Year
2018
2019
2020
2021
2022
2023
Total assets 90 137,65 29 810,65 25 104,13 19 699,34 14 826,48 13 124,57
A. Fixed assets 72 930,90 14 750,15 10 334,10 5 918,10 1 502,10 0,00
B. Current assets 17 206,75 15 060,50 14 770,03 13 781,24 13 324,38 13 124,57
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 90 137,65 29 810,65 25 104,13 19 699,34 14 826,48 13 124,57
A. Equity 35 197,38 28 790,98 23 543,03 18 310,67 13 068,81 10 997,90
B. Liabilities and provisions for liabilities 54 940,27 1 019,67 1 561,10 1 388,67 1 757,67 2 126,67
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 1 276,28 1 019,67 1 561,10 1 388,67 1 757,67 2 126,67
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.